उत्पाद वर्णन
Description
- Each Film Coated tablet Contains: Dapagliflozin propanediol USP, Eq. to Dapagliflozin 10mg, Glimepiride IP 2mg, Metformin Hydrochloride IP 1000mg
Doses
- As Directed by Physician.
Indication
- Dapagliflozin + Glimepiride + Metformin is a combination of three antidiabetic medications.
- Dapagliflozin lowers blood sugar by causing the kidneys to get rid of more glucose in the urine.
- Glimepiride lowers blood sugar by causing the pancreas to produce insulin (a natural substance that is needed to break down sugar in the body) and helping the body use insulin efficiently.
- Metformin helps to control the amount of glucose (sugar) in your blood. It decreases the amount of glucose you absorb from your food and the amount of glucose made by your liver.
- Metformin also increases your body's response to insulin, a natural substance that controls the amount of glucose in the blood.
Advanced Multi-Action Diabetes ControlThis combination tablet integrates three proven antidiabetic agents, targeting different mechanisms to effectively regulate blood sugar levels for individuals with type 2 diabetes mellitus. It aims to deliver comprehensive glycemic control by reducing glucose reabsorption, stimulating insulin, and enhancing insulin sensitivity.
Tailored for Convenient DosingBringing together Dapagliflozin, Glimepiride, and Metformin in one tablet streamlines diabetes management, reducing the need for multiple medications. The tablet's design and formulation facilitate daily consumption while ensuring stable and sustained therapeutic effects.
FAQ's of Dapagliflozin 10mg, Glimepiride IP 2mg, Metformin Hydrochloride IP 1000mg tab:
Q: How should Dapagliflozin 10mg, Glimepiride IP 2mg, and Metformin Hydrochloride IP 1000mg tablets be used?
A: These tablets are typically taken once daily, preferably with meals to minimize gastrointestinal side effects. It is important to follow your healthcare provider's instructions regarding dosage and timing.
Q: What are the benefits of using this combination tablet for type 2 diabetes mellitus?
A: This medication offers synergistic benefits by combining three antidiabetic agents. It helps control blood sugar levels through different modes of action, potentially leading to better glycemic management and reduced risk of diabetes complications.
Q: When is it appropriate to start using this medication?
A: This tablet is usually prescribed when lifestyle changes and monotherapy do not adequately control blood sugar in type 2 diabetes patients. Your healthcare provider will assess if this combination is suitable based on your medical history and current blood glucose levels.
Q: Where can this medication be procured in India?
A: The drug is available through a wide network of pharmaceutical dealers, distributors, exporters, importers, manufacturers, and retailers throughout India. Ensure you buy from licensed pharmacies or authorized suppliers.
Q: What is the appearance and shelf life of these tablets?
A: Each tablet is white or off-white, film-coated, and capsule-shaped, ensuring easy identification. The product maintains efficacy and safety for up to 24 months when stored as prescribed.
Q: What is the process for obtaining this medication from suppliers or dealers?
A: To acquire this medication, contact authorized pharmaceutical traders, wholesalers, or retailers in India. Medical prescription is generally required; consult with healthcare professionals for legal purchase guidelines.
Q: How do the individual ingredients contribute to diabetes management?
A: Dapagliflozin enhances glucose excretion via the kidneys, Glimepiride increases insulin secretion, and Metformin decreases liver glucose production while improving insulin sensitivity. Together, they provide robust blood glucose control in type 2 diabetes patients.